Reduction of left ventricular hypertrophy by Sirolimus in kidney transplant recipients: a nonrandomized clinical trial

Reduction of left ventricular hypertrophy by Sirolimus in kidney transplant recipients: a nonrandomized clinical trial

Background: Persistence of left ventricular hypertrophy (LVH) in renal transplant recipients is associated with unfavorable outcomes. Calcineurin-inhibitor (CNI) nephrotoxicity is a major cause of morbidity and mortality after kidney transplantation. In this study we compared sirolimus (SRL) with ca...

Full description

Bibliographic Details
Main Authors:	Sedghipour M, Tabatabaei SAH, Sadadi F, Kamal Hedayat D, Nikdoost F, Sate H, Ghorbani Yekta B
Format:	Article
Language:	fas
Published:	Tehran University of Medical Sciences 2012-02-01
Series:	Tehran University Medical Journal
Subjects:	Calcineurin inhibitor protein left ventricular hypertrophy (LVH) renal transplantation sirolimus transplant recipient
Online Access:	http://tumj.tums.ac.ir/browse.php?a_code=A-10-25-177&slc_lang=en&sid=1

Similar Items

De novo cancer avoidance after renal transplantation: A case–control study on low-dose sirolimus combined with a calcineurin inhibitor
by: Kuo-Hsin Chen, et al.
Published: (2015-06-01)

Development and validation of a rapid visual technique for left ventricular hypertrophy detection from the electrocardiogram
by: Sulaiman Somani, et al.
Published: (2023-08-01)

Use of sirolimus as an adjuvant therapy for kidney transplant recipients with high-risk cutaneous squamous cell carcinomas: a prospective non-randomized controlled study
by: Marina Rezende de Fázio, et al.
Published: (2023-08-01)

Conversion from calcineurin inhibitors to sirolimus of recipients with chronic kidney graft disease grade iii for a period 2003-2011
by: Ignjatović Ljiljana, et al.
Published: (2013-01-01)

Lymphedema attributed to sirolimus
by: Ardalan Mohammad-Reza
Published: (2013-04-01)

Sirolimus-induced bronchiolitis obliterans organizing pneumonia in a kidney transplant recipient; a case report and review of literature
by: Behzad Einollahi, et al.
Published: (2014-07-01)

Favorable Results of Concomitant Tacrolimus and Sirolimus Therapy in Taiwanese Renal Transplant Recipients at 12 Months
by: Kuo-Hsin Chen, et al.
Published: (2008-07-01)

The effect of calcineurin inhibitors on anthropometric measurements in kidney transplant recipients
by: Emel Isiktas Sayilar, et al.
Published: (2022-11-01)

Echocardiographic manifestations in patients on renal replacement therapy and renal transplant recipients
by: P L Vidya, et al.
Published: (2022-01-01)

Autophagy in kidney transplants of sirolimus treated recipients
by: Sagar Bhayana, et al.
Published: (2017-04-01)

Sirolimus in combination with low-dose extended-release tacrolimus in kidney transplant recipients
by: Zhi-yu Zou, et al.
Published: (2023-12-01)

How We Treated a Kidney Transplant Recipient Who Was Receiving Sirolimus During the SARS-CoV-2 Pandemic? Primum Non Nocere
by: Selcuk Yaylacı, et al.
Published: (2022-06-01)

Correlation between viral load of cytomegalovirus and tacrolimus and sirolimus levels in transplanted pediatric patients
by: Herlinda Reyes-Pérez, et al.
Published: (2016-01-01)

Safety and efficacy of Rapamune® (Sirolimus) in kidney transplant recipients: results of a prospective post-marketing surveillance study in Korea
by: Hee Jung Jeon, et al.
Published: (2018-08-01)

The Relationship Between Famine Exposure During Early Life and Left Ventricular Hypertrophy in Adulthood
by: Yu-qin Yan, et al.
Published: (2022-05-01)

Expression of soluble ST2 in patients with essential hypertension and its relationship with left ventricular hypertrophy
by: Peng Wei, et al.
Published: (2023-02-01)

Preservation of graft function in low-risk living kidney transplant recipients treated with a combination of sirolimus and cyclosporine
by: P.G.P. Machado, et al.
Published: (2004-09-01)

Electrocardiogram and echocardiographic study of left ventricular hypertrophy in patients with essential hypertension in a teaching medical college
by: K Venugopal, et al.
Published: (2016-01-01)

Reversible sirolimus-induced pulmonary alveolar proteinosis in a renal transplant patient
by: David Eugenio Hinojosa-González, et al.
Published: (2020-01-01)

Research Progress on the Efficacy and Safety of Spironolactone in Reversing Left Ventricular Hypertrophy in Hemodialysis Patients
by: Sun Z, et al.
Published: (2023-01-01)

Curcumin, an Inhibitor of p300-HAT Activity, Suppresses the Development of Hypertension-Induced Left Ventricular Hypertrophy with Preserved Ejection Fraction in Dahl Rats
by: Yoichi Sunagawa, et al.
Published: (2021-07-01)

PERIOPERATIVE PERIOD FOLLOWING HEART TRANSPLANTATION WITH SEVERE LEFT VENTRICULAR HYPERTROPHY
by: V. N. Poptsov, et al.
Published: (2012-05-01)

Sirolimus in Liver Transplant Recipients with Hepatocellular Carcinoma: An Updated Meta-Analysis
by: Zhi-Hua Zhang, et al.
Published: (2019-10-01)

Transplantation of cardiac allografts with left ventricular hypertrophy 1.5 cm and more
by: V. N. Poptsov, et al.
Published: (2019-05-01)

The side effect profile of sirolimus and its relationship with some variables: A retrospective study of Iranian renal transplant patients
by: Shahrzad Shahidi, et al.
Published: (2023-01-01)

Safety and effectiveness of everolimus compared with sirolimus and tacrolimus in preventing kidney transplantation rejection: a systematic review and meta-analysis
by: Morteza Arab Zozani, et al.
Published: (2015-08-01)

Diagnostic Accuracy of Electrocardiographic Criteria for Left Ventricular Hypertrophy in Thalassemia Syndrome
by: Sudigdo Sastroasmoro, et al.
Published: (2018-10-01)

Sirolimus potentiated angioedema: A case report and review of the literature
by: Beaini Hadi, et al.
Published: (2024-01-01)

Marinobufagenin, Left Ventricular Hypertrophy and Residual Renal Function in Kidney Transplant Recipients
by: Davide Bolignano, et al.
Published: (2023-04-01)

Recipient Management before Lung Transplantation
by: Hyoung Soo Kim, et al.
Published: (2022-08-01)

Sirolimus Prolongs Survival after Living Donor Liver Transplantation for Hepatocellular Carcinoma Beyond Milan Criteria: A Prospective, Randomised, Open-Label, Multicentre Phase 2 Trial
by: Kwang-Woong Lee, et al.
Published: (2020-10-01)

The effect of Valsalva maneuver on diastolic filling indices in patients with essential hypertension.
by: Salam A. Mahdi, et al.
Published: (2010-04-01)

Renal cancer in recipients of kidney transplant
by: Prajwal Dhakal, et al.
Published: (2017-03-01)

Automatic Identification of Patients With Unexplained Left Ventricular Hypertrophy in Electronic Health Record Data to Improve Targeted Treatment and Family Screening
by: Arjan Sammani, et al.
Published: (2022-04-01)

The Deceased Transplant Recipients: A Forgotten Source of Organ Donors
by: Dai D. Nghiem
Published: (2023-07-01)

Calcineurin inhibitors and arterial hypertension in recipients of solid organs
by: E D Kosmacheva, et al.
Published: (2017-12-01)

Calcineurin inhibitors and arterial hypertension in recipients of solid organs
by: Kosmacheva E.D., et al.
Published: (2017-09-01)

Left ventricular apical hypertrophy in a transplanted heart: a case report
by: Uzochukwu Ibe, et al.
Published: (2019-04-01)

Laparoscopic cholecystectomy in a cardiac transplant recipient
by: Seema R Pandya, et al.
Published: (2014-01-01)

The effect of post-traumatic growth on recovery in liver transplant recipients
by: Pinar Harmanci, et al.
Published: (2023-05-01)